• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉介入治疗(PCI)在既往冠状动脉旁路移植术(CABG)患者中的结局:多中心经验。

Outcomes following PCI in patients with previous CABG: a multi centre experience.

机构信息

Cardiothoracic Services, University Hospital of Wales, Heath Park, Cardiff, CF14 4XW, United Kingdom.

出版信息

Catheter Cardiovasc Interv. 2011 Aug 1;78(2):169-76. doi: 10.1002/ccd.22841. Epub 2011 Mar 16.

DOI:10.1002/ccd.22841
PMID:20939043
Abstract

BACKGROUND

Limited data is available to guide operators as to the optimal revascularisation strategy in patients with previous CABG representing with angina.

METHOD

Retrospective analysis of 161 patients with prior CABG undergoing PCI in two centres between September 2005 and April 2008.

RESULTS

161 patients (132 male, 68 ± 8 years) underwent PCI at 126 ± 65 months after index CABG. Clinical presentation of recurrent ischaemia was stable in 59.7% and as an acute coronary syndrome in 40.3% of patients. Mean follow-up after PCI was 13.5 ± 4.8 months. About 62.7% of patients underwent native vessel PCI, 32.9% had a graft only PCI, and 4.4% having a combination of both. Drug eluting stents were used in 84.9% of cases. There was one cardiac death and one case of redo CABG during follow-up. Mean CCS angina class decreased from 2.87 to 0.67 (P < 0.0001) in the follow-up group. About 13.6 % of all patients had a MACE at follow up. This was higher in the graft PCI group (21.6% vs. 8.9%, P = 0.048). About 12.4% of the total cohort underwent repeat PCI although 30% of these required PCI for a de-novo lesion. TVR rate was significantly higher in patients undergoing graft PCI than native vessel PCI (15% vs. 4.9%, P = 0.031). Graft PCI was an independent predictor (HR 3.73, 1.27-10.87 [95%CI], P = 0.016) of MACE in these patients.

CONCLUSION

PCI significantly improved angina in these patients with low overall rates of TVR. However TVR rate was significantly higher in patients undergoing graft PCI than those undergoing native vessel PCI.

摘要

背景

在先前接受过冠状动脉旁路移植术(CABG)并出现心绞痛的患者中,关于最佳血运重建策略的指导数据有限。

方法

对 2005 年 9 月至 2008 年 4 月期间在两个中心接受 PCI 的 161 例先前接受过 CABG 的患者进行回顾性分析。

结果

161 例患者(132 例男性,68±8 岁)在 CABG 后 126±65 个月行 PCI。复发性缺血的临床表现稳定的患者占 59.7%,急性冠状动脉综合征患者占 40.3%。PCI 后平均随访 13.5±4.8 个月。约 62.7%的患者行原血管 PCI,32.9%仅行桥血管 PCI,4.4%两者均行。84.9%的病例使用药物洗脱支架。随访期间发生心脏死亡 1 例,再次 CABG 1 例。随访组的 CCS 心绞痛分级从 2.87 降至 0.67(P<0.0001)。随访时约 13.6%的患者发生主要不良心血管事件(MACE)。桥血管 PCI 组的发生率(21.6%)高于仅原血管 PCI 组(8.9%)(P=0.048)。虽然总队列中有 30%的患者因新发病变而需要 PCI,但仍有 12.4%的患者行重复 PCI。行桥血管 PCI 的患者的 TVR 发生率显著高于行原血管 PCI 的患者(15% vs. 4.9%,P=0.031)。桥血管 PCI 是这些患者发生 MACE 的独立预测因素(HR 3.73,1.27-10.87[95%CI],P=0.016)。

结论

这些患者行 PCI 后心绞痛显著改善,TVR 的总体发生率较低。然而,行桥血管 PCI 的患者的 TVR 发生率明显高于行原血管 PCI 的患者。

相似文献

1
Outcomes following PCI in patients with previous CABG: a multi centre experience.经皮冠状动脉介入治疗(PCI)在既往冠状动脉旁路移植术(CABG)患者中的结局:多中心经验。
Catheter Cardiovasc Interv. 2011 Aug 1;78(2):169-76. doi: 10.1002/ccd.22841. Epub 2011 Mar 16.
2
Clinical outcome after surgical or percutaneous revascularization in coronary bypass graft failure.冠状动脉旁路移植失败后手术或经皮血运重建的临床转归。
J Cardiovasc Med (Hagerstown). 2013 Jun;14(6):438-45. doi: 10.2459/JCM.0b013e328356a4fc.
3
Comparison of percutaneous coronary intervention in native coronary arteries vs. bypass grafts in patients with prior coronary artery bypass graft surgery.既往接受冠状动脉旁路移植术患者的自身冠状动脉与旁路移植血管行经皮冠状动脉介入治疗的比较。
Cardiovasc Revasc Med. 2009 Apr-Jun;10(2):103-9. doi: 10.1016/j.carrev.2008.12.002.
4
Prior coronary artery bypass graft patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.经皮冠状动脉介入治疗治疗的前冠状动脉旁路移植术患者伴 ST 段抬高型心肌梗死。
JACC Cardiovasc Interv. 2010 Mar;3(3):343-51. doi: 10.1016/j.jcin.2009.12.008.
5
Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (strategic transcatheter evaluation of new therapies) group.药物洗脱支架与裸金属支架在静脉桥血管介入治疗中的结果来自 STENT(新疗法的策略性经导管评估)研究组。
JACC Cardiovasc Interv. 2009 Nov;2(11):1105-12. doi: 10.1016/j.jcin.2009.08.020.
6
Impact of chronic renal insufficiency on clinical outcomes in patients undergoing saphenous vein graft intervention with drug-eluting stents: a multicenter Southern Californian Registry.慢性肾功能不全对药物洗脱支架介入治疗大隐静脉桥患者临床结局的影响:多中心南加州注册研究。
Catheter Cardiovasc Interv. 2010 Aug 1;76(2):272-8. doi: 10.1002/ccd.22479.
7
Percutaneous coronary intervention for acute coronary syndrome due to graft failure: use of bare-metal and drug-eluting stents and subsequent long-term clinical outcome.经皮冠状动脉介入治疗因移植物失败导致的急性冠状动脉综合征:使用裸金属支架和药物洗脱支架以及随后的长期临床结果。
Catheter Cardiovasc Interv. 2014 Feb;83(2):203-9. doi: 10.1002/ccd.24441. Epub 2013 Oct 21.
8
Comparison of clinical outcomes in patients presenting with an acute coronary syndrome due to stent thrombosis or saphenous vein graft occlusion and undergoing percutaneous coronary intervention.因支架血栓形成或隐静脉桥闭塞而出现急性冠状动脉综合征并接受经皮冠状动脉介入治疗的患者的临床结局比较。
Cardiovasc Revasc Med. 2015 Dec;16(8):441-6. doi: 10.1016/j.carrev.2015.10.002. Epub 2015 Oct 24.
9
Revascularization in severe left ventricular dysfunction: outcome comparison of drug-eluting stent implantation versus coronary artery by-pass grafting.严重左心室功能不全的血运重建:药物洗脱支架植入与冠状动脉旁路移植术的疗效比较
Catheter Cardiovasc Interv. 2007 Jul 1;70(1):26-33. doi: 10.1002/ccd.21072.
10
Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial.在 SOS(静脉桥血管支架置入术)试验的长期随访中,紫杉醇洗脱支架与裸金属支架置入相比,在静脉桥病变中持续获益。
JACC Cardiovasc Interv. 2011 Feb;4(2):176-82. doi: 10.1016/j.jcin.2010.10.003.

引用本文的文献

1
Percutaneous Coronary Intervention of Native Artery Versus Bypass Graft in Patients with Prior Coronary Artery Bypass Graft Surgery.冠状动脉旁路移植术后患者行冠状动脉介入治疗:自体血管与移植血管的比较
Rev Cardiovasc Med. 2022 Jun 24;23(7):232. doi: 10.31083/j.rcm2307232. eCollection 2022 Jul.
2
Self-Expanding Versus Balloon Expanding Coronary Stents in Intervention of the Degenerated Saphenous Vein Graft: Memmingen Coronary Artery Bypass Stenosis Trial (MECAST).自膨式与球囊扩张式冠状动脉支架在退行性大隐静脉桥病变介入治疗中的比较:门兴格拉德巴赫冠状动脉旁路移植狭窄试验(MECAST)。
J Interv Cardiol. 2023 Apr 6;2023:9412132. doi: 10.1155/2023/9412132. eCollection 2023.
3
Clinical Characteristics, Management Strategies, and Outcomes of Non-ST-Segment-Elevation Myocardial Infarction Patients With and Without Prior Coronary Artery Bypass Grafting.
非 ST 段抬高型心肌梗死患者伴或不伴冠状动脉旁路移植术的临床特征、管理策略和结局。
J Am Heart Assoc. 2021 Oct 19;10(20):e018823. doi: 10.1161/JAHA.120.018823. Epub 2021 Oct 6.
4
Does Invasive Treatment Increase the Long-Term Survival of ST-Elevation Myocardial Infarction Patients with a History of Coronary Artery Bypass Graft Surgery?侵入性治疗能否提高有冠状动脉旁路移植术病史的ST段抬高型心肌梗死患者的长期生存率?
J Tehran Heart Cent. 2019 Jul;14(3):109-120.
5
Long-term outcomes of percutaneous coronary intervention in grafts and native vessels in coronary artery bypass grafting patients with diabetes mellitus.糖尿病冠状动脉旁路移植术患者移植血管和自身血管经皮冠状动脉介入治疗的长期预后
J Thorac Dis. 2019 Nov;11(11):4798-4806. doi: 10.21037/jtd.2019.10.33.
6
Comparison of Short-Term Results between Patients Undergoing Coronary Artery Bypass Graft with a Stent-Placement History and Patients Undergoing Primary Coronary Artery Surgery.有支架置入史的冠状动脉旁路移植患者与初次冠状动脉手术患者短期结果的比较。
J Tehran Heart Cent. 2019 Apr;14(2):53-58.
7
Current State of the Art in Approaches to Saphenous Vein Graft Interventions.大隐静脉移植血管干预方法的当前技术水平
Interv Cardiol. 2017 Sep;12(2):85-91. doi: 10.15420/icr.2017:4:2.
8
Saphenous vein graft interventions.大隐静脉移植干预措施。
Curr Treat Options Cardiovasc Med. 2014 May;16(5):301. doi: 10.1007/s11936-014-0301-x.